Programmed death-ligand 1 (PD-L1) is a transmembrane protein that binds the inhibitory receptor PD-1 on T cells, dampening antitumour immunity. Beyond transcriptional control, PD-L1 undergoes an array ...
As Merck & Co., Bristol Myers Squibb and Pfizer have hopped on the PD-(L)1xVEGF bispecific bandwagon, the question becomes how far the fanfare will spread. It’s more than just existing PD-1/L1 players ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results